Another reason might also be related to the stronger affinity of the 22C3 antibody to the PD-L1 on tumor cells, which could be observed as the staining of more tumor cells resulting in higher PD-L1 expression level or TPS, as compared with other antibodies against PD-L117. This evidence concerns the gene CD274 and neoplasm.